Trial intelligence / Profile preview

Metaxalone 640 mg vs 800 mg in Healthy Subjects

NCT06348303Phase 4Completed

Sponsor
Primus Pharmaceuticals
Start
May 2024
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metaxalone in Muscle spasm, sponsored by Primus Pharmaceuticals. Started May 2024; status: completed.

02

Drugs

metaxalone
03

Conditions

Muscle spasm

Beyond the preview

Go deeper on NCT06348303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06348303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call